Loading...
menu
Search
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
Home
ETF
NTLA
NTLA
-
Add to Watchlist
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
$
0.000
0.000
(
0.000%
)
At close
0.000
(
0.000%
)
Aft-market
ET
Overview
Technical
News
NTLA News
Biotech Sector Sees FDA Approvals and Layoffs
1d ago
NASDAQ.COM
Intellia Therapeutics Shows Significant Progress, Stock Up 58%
3d ago
Fool
Intellia Therapeutics' Drug Phase 3 Trial Success
3d ago
NASDAQ.COM
Intellia Therapeutics Shows Significant Progress, Stock Up 58%
3d ago
Yahoo Finance
Regentis Soars After Withdrawing US Listing Application
4d ago
NASDAQ.COM
Intellia's Treatment Candidate Shows Promising Results
4d ago
Yahoo Finance
Lonvo-z Trial Shows Significant Quality of Life Improvements for Patients
5d ago
stocktwits
Trump Announces Peace Framework with Iran, Easing Strait of Hormuz Concerns
5d ago
stocktwits
Intellia Reports Positive Phase 3 HAELO Trial Results for Lonvo-z
Jun 13 2026
Newsfilter
Buffett's Investment Strategy and Healthcare Opportunities
Jun 03 2026
Fool
Buffett and Abel's Investment Strategies
Jun 03 2026
NASDAQ.COM
FDA Issues Draft Guidance to Accelerate Gene Therapy Development
Jun 02 2026
seekingalpha
Intellia Announces HAELO Clinical Trial Data Presentation
Jun 01 2026
Newsfilter
Intellia Reports Positive Phase 3 Data for Lonvo-z, Plans U.S. Launch in 2027
May 11 2026
Newsfilter
Shopify and Others Tumble as Cathie Wood Buys on Dip
May 06 2026
Fool
Intellia Therapeutics to Participate in Upcoming Investor Conferences
May 05 2026
Newsfilter
Show More News
